TrialDaily Terms of Use
Use of the App
TrialDaily reports on publicly registered clinical trials and published U.S. FDA regulatory actions for informational and research awareness. It is not medical advice, it provides no diagnosis or treatment recommendations, and nothing in it should be relied on as a basis for care decisions. Consult a qualified clinician about your health. TrialDaily is not affiliated with or endorsed by ClinicalTrials.gov, the U.S. Food and Drug Administration, the National Institutes of Health, or any U.S. government agency. Always read the linked primary record before acting.
Paid Features
Free readers get the day's lead story. TrialDaily Premium is an auto-renewable subscription for $6.99/month or $59.99/year with a 7-day free trial on first purchase, sold through Apple In-App Purchase. Premium unlocks the full daily briefing, the complete archive, and search. Payment is charged to your Apple ID at confirmation, renews automatically unless cancelled at least 24 hours before the end of the current period, and can be managed or cancelled in your Apple ID settings.
Availability
Briefings publish on weekdays and depend on ClinicalTrials.gov, openFDA, and the FDA newsroom being reachable, on backend processing, and on network access. openFDA and ClinicalTrials.gov index records on their own schedules, so a briefing reports what has become publicly visible rather than the moment an action was decided. In-app purchase prices can vary by region and App Store account state.
Support
For product or account questions, contact gosingk@gmail.com. These terms are maintained by WU HAOTIAN.